edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Healthcare
Kuros Biosciences raised its 2025 sales guidance to at least 70% growth after reporting a 77% revenue surge to $101.1m for the first nine months of 2025. The Swiss medical device company’s Direct MagnetOs sales jumped 76% to $99.7m, driven by strong demand for its bone graft technology. Kuros reported EBITDA of $7.4m, up from $1.6m a year earlier, delivering a 12.1% adjusted EBITDA margin. The company launched its MagnetOs MIS Delivery System in the US following FDA clearance and secured Saudi Food and Drug Authority approval for MagnetOs Putty and Granules.
Industrials | Comment
TMT | Comment
Industrials | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.